MENTOR, Ohio -- STERIS Corporation announces that its subsidiary, Strategic Technology Enterprises, Inc., has been awarded a contract by Jet Propulsion Laboratory (JPL), a NASA contract laboratory, to conduct research and development activities to optimize and certify a STERIS patented proprietary sterilization technology for application in the sterilization of robotic planetary spacecraft systems and sub-systems. JPL is pursuing this certification to meet NASA's sterility requirements on future space exploration missions.
Strategic Technology Enterprises will provide STERIS's patented technology along with a specially designed and manufactured sterilization chamber to perform a variety of experiments. The goal of the research is to demonstrate the effectiveness of the technology in killing a selection of microorganisms known to be highly resistant to sterilization that are typically found in spacecraft assembly areas. JPL, in conjunction with NASA's Planetary Protection Office, will investigate the parameters required by NASA to certify the sterilization process. Specific terms of the agreement were not disclosed.
Commenting on the agreement, Les C. Vinney, STERIS's president and CEO, said, "We are pleased to be working with NASA and supporting their efforts to explore our solar system. STERIS technologies are used to sterilize and decontaminate critical environments everyday in the healthcare, pharmaceutical, and research industries worldwide. This agreement reinforces our belief that our technologies can be used in even broader applications, and represents one of several steps we are taking to adapt our technologies to new markets, a key element of our growth strategy. We look forward to working with NASA on this and future projects."
STERIS provides an array of technologies that have been proven highly effective against a range of pathogenic organisms and bacterial spores. In addition to sterilizing medical devices, these technologies are used to sterilize and decontaminate building environments, including entire rooms and their contents, as well as sensitive electronic equipment, ductwork, research isolators, and other artifacts.
STERIS Corporation is a leading provider of infection prevention, contamination prevention, microbial reduction, and surgical support systems, products, services and technologies to healthcare, scientific, research, industrial, and government customers throughout the world.
Jet Propulsion Laboratory is a division of the California Institute of Technology in Pasadena, Calif.
Source: STERIS
AHE Exchange Summit 2025 Brings EVS and Infection Prevention Experts Together in Columbus, Ohio
June 9th 2025The Association for the Health Care Environment (AHE) is set to host its largest event of the year—Exchange Summit 2025—from June 8 to 11 in Columbus, Ohio. With over 600 environmental services (EVS) professionals expected to attend, this year’s conference focuses heavily on infection prevention, interdepartmental collaboration, and education that empowers frontline health care support leaders to improve patient safety and operational efficiency.
Far UV-C Light Shows Promise for Decontaminating Medical Equipment in Clinical Settings
June 4th 2025Manual cleaning gaps on shared hospital equipment can undermine infection control efforts. New research shows far UV-C light can serve as a safe, automated backup to reduce contamination in real-world clinical settings.
Unmasking Vaccine Myths: Dr Marschall Runge on Measles, Misinformation, and Public Health Solutions
May 29th 2025As measles cases climb across the US, discredited myths continue to undercut public trust in vaccines. In an exclusive interview with Infection Control Today, Michigan Medicine’s Marschall Runge, PhD, confronts misinformation head-on and explores how clinicians can counter it with science, empathy, and community engagement.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.